Compounds for neutron capture therapy and their distribution in tumors and surrounding tissues of animals (A review)
Boron-containing compounds for neutron capture therapy (NCT) can be divided into three groups: compounds without specific accumulation in tumor, tumor-selective compounds, and compounds capable of incorporating into the structure of tumor cells. For the NCT of cancer patients, sodium mercaptododecaborate (BSH) and p-boronophenylalanine (BPA) were selected from several hundred of boron-containing compounds. In this paper, data on the distribution of BSH and BPAin the organism of animals with model tumors modeling those encountered in oncological patients are reviewed. Methods for increasing the boron uptake in tumor, based on the combined use of boron compounds and modification factors such as hyperthermia, effect of electric pulses on the tumor zone, administration of compounds possessing vasodilating properties and influencing the blood-brain barrier permeability, are considered.
KeywordsMelanoma Boron Boron Atom Boron Neutron Capture Therapy Neutron Capture Reaction
Unable to display preview. Download preview PDF.
- 2.M. F. Hawthome, Molec. Med. Today, April, 174–181 (1998).Google Scholar
- 10.G. E. Laramore, R. Risler, T. W. Griffin, et al., Bull. Cancer / Radiother., 83(Suppl. 1), 191s–197s (1996).Google Scholar
- 11.E. Heber, E. L. Kreimann, D. Nigg, et al., in: Research and Development in Neutron Capture Therapy, W. Sauerwein, R. Moss, and A. Witting (eds.), Monduzzi, Essen (2002), pp. 745–749.Google Scholar
- 21.J. Capala, K. Skold, B. H. Stenstam, et al., in: Research and Development in Neutron Capture Therapy, W. Sauerwein, R. Moss, and A. Witting (eds.), Monduzzi, Essen (2002), pp. 1101–1106.Google Scholar
- 40.W. S. Kiger, C. F. Chuang, M. R. Palmer, et al., in: Research and Development in Neutron Capture Therapy, W. Sauerwein, R. Moss, and A. Witting (eds.), Monduzzi, Essen (2002), pp. 765–768.Google Scholar